top of page

Tech-enabled DSUR literature review driven by biologit

Writer's picture: Nicole BakerNicole Baker

Updated: Oct 17, 2024


Proven Results with biologit

At biologit, we are dedicated to supporting our clients with their pharmacovigilance needs. We recently supported a clinical biotech company by streamlining their DSUR literature review process to produce results in less than 5 days, and on budget. As a result of our cutting-edge platform and database, biologit was able to:


  • Review over 10,000 articles

  • Identify and remove 4,771 duplicates

  • Pinpoint 16 relevant safety articles


Contact us to learn more about how we can support you. 

Comments


Commenting has been turned off.
bottom of page